UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

JNCI : Journal of the National Cancer Institute, 1991-12, Vol.83 (24), p.1797-1805

1991

Volltextzugriff (PDF)

Classification and Regression Tree Analysis of 1000 Consecutive Patients with Unknown Primary Carcinoma

Clinical cancer research, 1999-11, Vol.5 (11), p.3403-3410

1999

Volltextzugriff (PDF)

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin

Journal of clinical oncology, 1995-08, Vol.13 (8), p.2094-2103

1995

Volltextzugriff (PDF)

Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 1993-03, Vol.85 (5), p.384-388

1993

Volltextzugriff (PDF)

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1272-1280

1994

Volltextzugriff (PDF)

Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors

Annals of oncology, 1998-09, Vol.9 (9), p.1003-1008

1998

Volltextzugriff (PDF)

Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?

Journal of clinical oncology, 1997-05, Vol.15 (5), p.2056-2066

1997

Volltextzugriff (PDF)

Unknown primary tumors metastatic to liver

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2105-2112

1998

Volltextzugriff (PDF)

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

International journal of clinical oncology, 2014-06, Vol.19 (3), p.479-484

2014

Volltextzugriff (PDF)

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy

Journal of clinical oncology, 1996-02, Vol.14 (2), p.503-513

1996

Volltextzugriff (PDF)

Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center

Journal of clinical oncology, 1996-01, Vol.14 (1), p.287-295

1996

Volltextzugriff (PDF)

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

Journal of clinical oncology, 1991-03, Vol.9 (3), p.491-498

1991

Volltextzugriff (PDF)

The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®)

Cancer treatment reviews, 1993-10, Vol.19 (4), p.351-386

1993

Volltextzugriff (PDF)

Phase I evaluation of all-trans-retinoic acid in adults with solid tumors

Journal of clinical oncology, 1993-05, Vol.11 (5), p.959-966

1993

Volltextzugriff (PDF)

Flow cytometry in clinical cancer research

Cancer research (Chicago, Ill.), 1983-09, Vol.43 (9), p.3982-3997

1983

Volltextzugriff (PDF)

Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors

Journal of clinical oncology, 1995-06, Vol.13 (6), p.1501-1508

1995

Volltextzugriff (PDF)

Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II)

Cancer research (Chicago, Ill.), 1990-07, Vol.50 (14), p.4254-4259

1990

Volltextzugriff (PDF)

Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor

Clinical cancer research, 1996-09, Vol.2 (9), p.1489-1497

1996

Volltextzugriff (PDF)

Metastatic patterns in adenocarcinoma

Cancer, 2006-04, Vol.106 (7), p.1624-1633

2006

Volltextzugriff (PDF)

The biology of unknown primary tumors

Seminars in oncology, 1993-06, Vol.20 (3), p.238-243

1993

Volltextzugriff (PDF)

Clinical pharmacology of combined oral uracil and ftorafur

Drug metabolism and disposition, 1992-11, Vol.20 (6), p.936

1992

Volltextzugriff (PDF)

Phase I Trial of Taxotere: Five-Day Schedule

JNCI : Journal of the National Cancer Institute, 1992-12, Vol.84 (23), p.1781-1788

1992

Volltextzugriff (PDF)

A patient's perspective on cancer‐related fatigue

Cancer, 2001-09, Vol.92 (S6), p.1662-1663

Raber, Martin N.

2001

Volltextzugriff (PDF)

Phase II clinical trial of didemnin B in previously treated small cell lung cancer

Investigational new drugs, 1994-09, Vol.12 (3), p.243-249

1994

Volltextzugriff (PDF)

Are Time or Intensity Factors Important to the Definition of Metastases of Unknown Origin?

JNCI : Journal of the National Cancer Institute, 1996-04, Vol.88 (7), p.462-463

1996

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(186)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

Classification and Regression Tree Analysis of 1000 Consecutive Patients with Unknown Primary Carcinoma

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin

Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors

Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?

Unknown primary tumors metastatic to liver

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy

Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®)

Phase I evaluation of all-trans-retinoic acid in adults with solid tumors

Flow cytometry in clinical cancer research

Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors

Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II)

Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor

Metastatic patterns in adenocarcinoma

The biology of unknown primary tumors

Clinical pharmacology of combined oral uracil and ftorafur

Phase I Trial of Taxotere: Five-Day Schedule

A patient's perspective on cancer‐related fatigue

Phase II clinical trial of didemnin B in previously treated small cell lung cancer

Are Time or Intensity Factors Important to the Definition of Metastases of Unknown Origin?

Suchergebnisse filtern